Irisin: A Potential Promising Agent Against Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Rats

Non-alcoholic fatty liver disease (NAFLD) represents a growing cause of liver morbidity and mortality globally with no proven effective therapy yet. The aim of this research is to investigate the effect of vitamin D treatment on choline deficient (CD) diet-induced nonalcoholic fatty liver disease (NAFLD) like lesions in rats, with the possible involvement of irisin in this effect. Thirtytwo rats were divided into 4 equal groups; control group, vitamin D group, CD diet group, CD diet+ vitamin D group. It was found that CD diet led to significant elevations in liver weight and index, serum liver enzymes, hepatic triglycerides (TG), malondialdehyde (MDA), inflammatory markers with significant decreases in serum 25-(OH) D3, irisin, hepatic antioxidants and peroxisome proliferator-activated receptor alpha (PPAR-α). Administration of vitamin D caused a significant improvement in all previous parameters, these results were supported by histopathological examination. It seems that vitamin D supplementation significantly reduced NAFLD induced by CD diet even in part due to irisin. Keywords-Irisin -vitamin D -fatty liver Bull. of Egyp. Soc. Physiol. Sci.

show abstract

Irisin contributes to the hepatoprotective effect of vitamin D in a choline deficient diet induced nonalcoholic fatty liver disease rat model.

Anwer

Hani

El-Shaer

et al. 2021

BESPS

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Irisin: A Potential Promising Agent Against Non-Alcoholic Fatty Liver Disease in Type 2 Diabetic Rats

Cited by 1 publication

References 50 publications

Irisin contributes to the hepatoprotective effect of vitamin D in a choline deficient diet induced nonalcoholic fatty liver disease rat model.

Irisin contributes to the hepatoprotective effect of vitamin D in a choline deficient diet induced nonalcoholic fatty liver disease rat model.

Contact Info

Product

Resources

About